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Increased pathogenicity of pneumococcal serotype
1 is driven by rapid autolysis and release of
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Streptococcus pneumoniae serotype 1 is the predominant cause of invasive pneumococcal
disease in sub-Saharan Africa, but the mechanism behind its increased invasiveness is not
well understood. Here, we use mouse models of lung infection to identify virulence factors
associated with severe bacteraemic pneumonia during serotype-1 (ST217) infection. We use
BALB/c mice, which are highly resistant to pneumococcal pneumonia when infected with
other serotypes. However, we observe 100% mortality and high levels of bacteraemia within
24 hours when BALB/c mice are intranasally infected with ST217. Serotype 1 produces large
quantities of pneumolysin, which is rapidly released due to high levels of bacterial autolysis.
This leads to substantial levels of cellular cytotoxicity and breakdown of tight junctions
between cells, allowing a route for rapid bacterial dissemination from the respiratory tract
into the blood. Thus, our results offer an explanation for the increased invasiveness of
serotype 1.
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S treptococcus pneumoniae (the pneumococcus) is a majorhuman pathogen responsible for a range of severe diseasesincluding pneumonia, meningitis and bacteraemia1. The
pneumococcus accounts for significant morbidity and mortality
globally, particularly in high risk groups such as the elderly,
infants and the immunocompromised2.
Serotype 1 has unusual clinical, epidemiological, genetic and
microbiological characteristics, making it the most prevalent of
the highly invasive pneumococcal serotypes in sub-Saharan
Africa3–6. Disease rates in the young and in otherwise healthy
adults are high, whilst carriage rates are low, even when symp-
tomatic disease is prevalent in the population3,7. Epidemiological
studies have found that serotype 1 causes a large proportion of
the pneumococcal disease seen in HIV-uninfected children,
suggesting that serotype 1 is highly virulent and more invasive
than other serotypes, enabling it to cause disease in otherwise
healthy individuals7–10. Despite temporal reductions in disease
incidence after the introduction of the Pneumococcal Conjugate
Vaccine (PCV13) in 2011, serotype 1 remains the most common
serotype causing invasive pneumococcal disease (IPD) in South-
ern and sub-Saharan Africa11.
The pneumococcal toxin pneumolysin is expressed by virtually
all clinical isolates and has been described as a key virulence
factor contributing to high morbidity and mortality rates in
invasive disease12–16. Pneumolysin is a member of the cholesterol
dependent cytolysin (CDC) family of membrane-binding tox-
ins17. It lyses cells with cholesterol in their membranes, activates
host complement and induces pro-inflammatory reactions in
immune cells18,19. For example, experiments in human lung tis-
sue demonstrate that detection of pneumolysin by NLRP3
inflammasomes mediates production of inflammatory cytokines
such as IL-1β and IL-820. At lytic concentrations, pneumolysin
causes widespread cellular and tissue damage, allowing for
increased bacterial replication and tissue invasion14. As pneu-
molysin is a cytosolic toxin, release is mediated by an autolysin-
dependant process21. This process is characterised by cell wall
degradation by a peptidoglycan hydrolase (autolysin), the most
common of which is known as LytA22. As pneumolysin lacks an
N terminal secretion signal sequence, lysis of the bacteria by
autolysin is essential for toxin release21,23,24. Genetically designed
pneumolysin-deficient (PLY-) and autolysin (LytA−) deficient
mutant pneumococcal strains have been shown to be attenuated
in virulence after intranasal administration into mice12,25–28.
Hence, pneumolysin and autolysin work hand in hand as key
pneumococcal virulence factors.
The presence of cytotoxic pneumolysin in the lung during the
initial phase of pneumonia contributes to the development of
bacteraemia, facilitating penetration of bacteria from the alveoli
into the interstitium of the lung, and dissemination of pneumo-
cocci into the bloodstream, during experimental models of
pneumonia29,30.
The importance of pneumolysin in pneumococcal carriage and
invasive disease has been well characterised in serotype 2 (D39)
infection but little is known about the combinations of key
virulence factors that contribute to serotype 1 disease pathogen-
esis. Post vaccine studies are ongoing to monitor the effect of
PCV13 introduction on serotype 1 distribution, however, an
indirect cohort analysis from a surveillance programme failed to
demonstrate significant protection against serotype 1 IPD by
PCV1331. In addition, phylogenetic analysis of invasive serotype 1
pneumococcal isolates in South Africa show increases in genetic
diversity and an increase of lineages associated with antimicrobial
non-susceptibility post-PCV1311. Hence, an understanding of the
contribution of key virulence factors to pneumococcal patho-
genesis could aid both future vaccine design and potential ther-
apeutics for serotype 1 IPD.
To identify factors that make key contributions to serotype 1
disease pathogenesis, we used murine models of experimental
pneumococcal pneumonia and nasopharyngeal carriage. Experi-
ments were performed with the pneumococcal pneumonia-
resistant BALB/c strain of mice32–34, and disease severity of
infection with African serotype 1 (ST217 and ST3081) was
compared to serotypes 2 (D39), 5, 6B and 7F infection. African
serotype 1 clonal complex ST217 was used, as this has been the
dominant clone amongst serotype 1 isolates in Africa since
19896,11.
Here, we demonstrate that in a normally resistant BALB/c
pneumonia model, African serotype 1 induced 100% mortality,
whilst mice challenged with the other serotypes all survived.
Serotype 1 virulence was driven by rapid bacterial autolysis,
which leads to the release of large quantities of pneumolysin,
enabling rapid bacterial dissemination into the bloodstream.
Results
Serotype 1 pneumococci display high tissue invasiveness.
BALB/c mice intranasally infected with 106 colony forming units
(CFU) of serotype 1 (ST217) displayed 100% mortality within
48 h of infection, compared with 0% mortality in mice infected
with the same concentration of serotype 2 (D39) (Fig. 1a).
In addition, as early as 6 h post-infection, 60% of serotype 1
infected mice had significant bacteremia (mean CFU: 5 × 104 cfu
per ml), increasing to 100% of mice by 12 h post infection until
time of death (mean CFU: 3 × 106 cfu per ml). No bacteria were
detectable in the blood of serotype 2 (D39)-infected mice at any
time point tested (Fig. 1b). Despite these significant differences in
bacteremia, no significant differences in lung bacterial loads were
observed between serotype 2 and serotype 1-infected mice over
the first 12 h post infection (Fig. 1c) and so we hypothesised that
the level of bacterial load in lungs is not directly responsible for
bacterial dissemination into the blood stream in this murine
model of pneumonia.
Lung tissue from naïve and S. pneumoniae-infected mice was
used to examine damage, via histopathology, during pneumo-
coccal pneumonia (Fig. 2). Substantially greater levels of immune
cell infiltration, inflammation and pathology were observed in
ST217-infected lungs as compared to D39 at equivalent time-
points. By 18 h post-infection, lungs infected with ST217
exhibited hypertrophy of bronchiole walls, heavy cellular
infiltration around bronchioles and evidence of oedema. By
24 h post-infection, extension of inflammatory cell infiltration
from bronchioles and perivascular areas into the surrounding
lung parenchyma was apparent with several focal areas of heavy
consolidation becoming larger and more diffuse. Although a
gradual increase in cellular infiltration and inflammation was also
observed in D39-infected lungs, this was substantially less
prominent than that seen in ST217-infected lungs.
Immune cell analysis of ST217 and D39 infected lungs was
performed at 6, 12 and 24 hours post infection (Supplementary
Figs. 1A–C, 9 and 10). Mice infected with ST217 had significantly
higher numbers of Gr-1+ neutrophils in the lungs 6 h post
infection compared to D39-infected mice (P < 0.01) and this
trend continued at 12 and 24 h post-infection, despite equivalent
CFU levels across these timepoints in D39 and ST217-infected
mice, again suggesting that the drivers of inflammation are not
bacterial numbers alone. Interestingly, despite early increases in
Foxp3+ T regulatory cell numbers in ST217-infected lungs, by
24 h post-infection D39-infected mice had significantly higher
numbers of Foxp3+ cells.
Dissemination of serotype 1 (ST217) in a non-lethal murine
nasopharyngeal carriage model was also investigated (Fig. 3).
During a 21-day carriage experiment in BALB/c mice, comparing
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D39 and ST217 carriage patterns, nasopharyngeal bacterial
burdens were comparable on all days except day 7 post infection
when a significantly higher density of serotype 1 colonisation was
detected (Fig. 3a). This higher density of serotype 1 colonisation
prevailed over the next 14 days. Flow cytometry was performed to
analyse the fluctuation of immune cell numbers in the
nasopharynx over 21 days of colonisation in ST217-infected
mice compared to D39-infected (Supplementary Figs. 1d–g, 10
and 11). Both groups of infected mice showed a similar trend of
neutrophil (CD45+ Gr-1+) and macrophage (CD45+ CD11b+
F4/80+) numbers over time. A significant difference in both
neutrophil and macrophage numbers was observed at day 14 post
infection with D39-infected mice showing higher numbers of
macrophages and neutrophils compared to ST217-infected mice.
In addition, cells associated with the adaptive immune response
were also monitored over 21 days in the nasopharynx. No
significant differences in the numbers of Foxp3+ T regulatory
cells or RORγT+ Th17 cells were observed between ST217 and
D39 colonisation. In addition, no significant differences were
observed in the number of Foxp3+ cells expressing TGFβ or Th17
cells expressing IL-17A between infection with the different
serotypes.
Of note, serotype 1 was able to invade and colonise the olfactory
tissues at a substantially higher density over 14 days than D39,
with significantly higher ST217 CFU at days 5 and 7 post infection
in olfactory epithelia and bulb respectively (Fig. 3b, c). Impor-
tantly, while serotype 1 colonies were detected in the brain during
the first 7 days of nasopharyngeal carriage, no D39 colonies were
detected throughout this experiment (Fig. 3d), demonstrating the
capacity of serotype 1 to translocate across nasopharyngeal to
olfactory and ultimately brain tissue.
Neither ST217, nor D39, colonies were detected in the blood at
any timepoint (data not shown), suggesting that serotype 1 may
utilise host invasion of olfactory tissues to enter the brain, bypassing
the blood-brain barrier. Indeed, direct invasion from the nasophar-
ynx to the brain via the olfactory tissues has been previously
reported for serotype 19F, in immunocompromised XID mice that
are highly susceptible to pneumococcal infection35. To the best of
our knowledge, this is the first reported description of this pathway
of translocation from nasopharyngeal tissues to meninges for
Streptococcus pneumoniae in immunocompetent mice.
Comparison of invasive clinical isolates in a pneumonia model.
To assess whether high mortality rates in resistant BALB/c mice
were unique to serotype 1 (ST217) infection, the pneumonia
survival model was repeated with different clinical isolates of S.
pneumoniae (Fig. 4a). The isolates tested included the invasive
clinical serotypes 1, 5, 7F and 6B, all of which are included in the
current PCV13 vaccine36. Additional serotype 1 isolates were also
included in these experiments, including another ST217 isolate
from Karonga, Malawi (ST217C), an ST3081 from the Gambia
and a European serotype 1 isolate (ST306) expressing a non-
haemolytic pneumolysin. Strikingly, while 100% mortality was
observed in BALB/c mice infected with all African serotype 1
isolates (ST217S, ST217C and ST3081), 100% survival was seen
with all other serotypes tested, including the non-haemolytic
serotype 1 strain ST306 (Fig. 4a).
Comparison of pneumolysin production in clinical isolates.
ST306 expresses a non-haemolytic pneumolysin and was the only
serotype 1 sequence type not to cause any mortality in vivo,
further suggesting that pneumolysin is a key determinant of
serotype 1 virulence in vivo. The amount of pneumolysin released
upon total lysis of 107 CFU of different pneumococcal serotypes
was determined by ELISA (Fig. 4b). Total pneumolysin content of
lysed CFU varied considerably between isolates, from 20 ng per
ml for serotype 19F to over 400 ng per ml for serotype 1 (ST306)
(Fig. 4b). Serotype 1 isolates produced between 200 and 420 ng of
pneumolysin upon lysis, a range of production at the upper end
of the strains tested, and significantly more than that produced by
D39, but comparable with that of the non-lethal serotype 5 and
7F strains.
In order to determine whether pneumolysin was one of the
factors responsible for ST217 virulence, we replaced the ply gene
of D39 with that of ST217. Mice infected with D39:ST217ply
showed a phenotype intermediate between those infected with
D39 and those infected with ST217. We observed 50% mortality
in D39:ST217ply infected mice (Fig. 4a, Supplementary Fig. 2a)
and bacteraemia was observed as early as 3 h post-infection
(Supplementary Fig. 2b). However, by 24 h post-infection, only
50% of mice remained bacteraemic (Supplementary Fig. 2b),
compared with 100% of ST217-infected animals (Fig. 1b). D39:
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Fig. 1 Comparison of Serotype 1 (ST217S) and Serotype 2 (D39) in
BALB/c mouse pneumonia model. a Kaplan–Meier survival curve showing
survival times of mice infected intranasally (IN) with 1 × 106 colony forming
units (CFU) of serotype 1 (ST217S) (red line) or serotype 2 (D39) (black
line). 1 (ST217S) infected mice n= 9 and 2 (D39) infected mice n= 10.
b Blood bacterial load in 1 (ST217S) infected mice (red dots) and 2 (D39)
infected mice (black dots) at 1,3, 6, 12, 18 and 24 h post intranasal infection
(CFU per ml). c Lung bacterial load in 1 (ST217S) infected mice (red dots)
and 2 (D39) infected mice (black dots) at 1, 3, 6 12, 18 and 24 h post
intranasal infection CFU per mg) (each dot represents one mouse). Data
are presented as follows; each symbol represents an individual mouse and
geometric mean is shown by horizontal bars. Statistical analysis was
performed using Two-way ANOVA and Sidaks’s post-test. ***P-value=
0.0001, ****P-value < 0.0001. Source data are provided as a Source
Data file.
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ST217ply expressed levels of pneumolysin that were significantly
higher than D39 and comparable to those of ST217 (Fig. 4b),
suggesting that virulence of ST217 is at least partially due to high
levels of pneumolysin production.
Significantly higher autolysis rates found in Serotype 1 isolates.
The release of pneumolysin depends upon autolysin-dependent
lysis of pneumococci37. As autolysis is a key determinant of toxin
release, measurements of bacterial autolysis were used to assess
the amount of pneumolysin released from the cytoplasm of
the cells.
Triton-X induced autolysis assays were performed to assess the
relative rates of autolysis amongst different pneumococcal isolates
with moderate to high levels of pneumolysin production (Fig. 4c
and Supplementary Fig. 3). A D39 LytA knockout mutant (LytA−)
was used as a control in these experiments to show that Triton-X
induced autolysis was dependent on LytA activation. OD600
readings significantly decreased (shown as percentage increase in
autolysis) for serotype 1; ST3081, ST217C, ST217S and D39:
ST217ply strains 60 min after Triton X treatment compared to
serotype 2 (D39). Interestingly, although serotype 5 produced
pneumolysin levels comparable with those of serotype 1, it caused
no mortality in the BALB/c pneumonia model and rates of
Triton-X induced autolysis were found to be significantly lower in
serotype 5 compared to serotype 1 isolates after 60 min of Triton
X treatment. Consistent with its intermediate virulence pheno-
type, the D39 strain expressing the ST217 pneumolysin (D39:
ST217ply) had an autolysis rate that was significantly higher than
that of the parental D39 strain but lower than that of the serotype
1 isolates. Serotype 5 and the D39:ST217ply strain had initially
high autolysis rates but these plateaued between 60 and 120 min
post Triton X treatment (Supplementary Fig. 3). These findings
suggest that autolysis is significantly more rapid in serotype 1,
leading to enhanced release of pneumolysin, as compared to other
serotypes.
Serotype 1 supernatant aids virulence of D39 in pneumonia
model. To examine whether natural rates of autolysis (not
induced by Triton-X) might contribute to in vivo virulence, and to
determine whether extracellular pneumolysin within the super-
natant of the infection inoculum might impact on disease pro-
gression, a supernatant switch experiment was designed. Serotype
1 (ST217S) and serotype 2 (D39) inoculum doses (2 × 107
CFU each) were prepared in 1 ml of PBS. The doses were
Naïve lung
200 µm 200 µm
200 µm200 µm
200 µm200 µm
200 µm200 µm
200 µm200 µm
D39-infected lung 18 h post infection
D39-infected lung 24 h post infection
ST217-infected lung 18 h post infection
ST217-infected lung 24 h post infection
Fig. 2 Lung histopathology during murine pneumonia infection with Serotype 1 (ST217) and Serotype 2 (D39) S. pneumoniae. Mice were infected as
described in Fig. 1. Lung sections from infected mice were stained with haematoxylin and eosin to show changes in lung pathology during pneumococcal
infection with either 1 (ST217S) or 2(D39) at 18 and 24 h post infection (5 mice/group/timepoint). Lung sections from naïve mice (n= 5) are also shown.
Scale bars= 200 μm.
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incubated for 60 min at room temperature. An ELISA-based
detection method was used to measure the concentration of
pneumolysin released into the inoculum dose during this time
period (the supernatant). PLN-A (isogenic pneumolysin-negative
mutant of D39) was used as a pneumolysin-negative control.
Results demonstrate that the serotype 1 inoculum had sig-
nificantly higher concentrations of pneumolysin in its super-
natant compared to the D39 supernatant (***P= 0.0002;
Fig. 5a). To investigate the effect of high concentrations of
supernatant pneumolysin in the serotype 1 inoculum dose on
induction of disease, the supernatants of serotype 1 and D39
inoculum doses were swapped before infection of the mice. D39
and serotype 1 infection doses were prepared in 1 ml of PBS,
incubated at room temperature for 60 min and then immediately
prior to infection, bacteria were pelleted by centrifugation and the
supernatants of the two doses were swapped. Mice were infected
with either D39 bacteria resuspended in supernatant from ser-
otype 1 (ST217S) inoculum dose or serotype 1 (ST217S) bacteria
resuspended in supernatant from D39 inoculum dose.
High concentrations of pneumolysin in the supernatant of
inoculum doses contributed significantly to mortality in the
mouse pneumonia model (Fig. 5b). When mice were infected
with serotype 1 bacteria and serotype 1 supernatant, 100%
mortality was observed with a mean survival time of 25 h
compared to 100% survival in mice infected with D39 bacteria in
D39 supernatant. When mice were infected with D39 bacteria
with serotype 1 supernatant, survival rates decreased from 100%
to 40%, with a mean survival time of 62.5 h, and when mice were
infected with serotype 1 bacteria with D39 supernatant, mean
survival time increased from 25 h to 48 h and 20% survival rates
were observed. Finally, when serotype 1 supernatant was pre-
treated with cholesterol-containing liposomes (which we have
previously shown to strongly bind and sequester pneumolysin)38
prior to resuspension of the D39 pellet and infection of mice,
survival rates returned to 100%, confirming that the serotype 1
pneumolysin in the supernatant is responsible for increased
mortality in D39-infected mice.
Cytotoxic effects of serotype 1 pneumolysin on lung epithelial
cells. Excess concentrations of pneumolysin in the lung have
previously been shown to aid bacterial replication and increase
rates of tissue invasion and dissemination into the
bloodstream14,30. Lactate dehydrogenase (LDH) assays were used
to measure cytotoxicity of A549 human lung epithelial cells upon
infection with a range of clinical serotypes of S. pneumoniae
in vitro. Infection with serotype 1 (ST217S) caused significantly
more cytotoxic damage to lung epithelial cells compared to other
serotypes at equivalent CFU load (Fig. 6). At 6 h post infection,
lung epithelial cells cultured with serotype 1 (ST217S) had sig-
nificantly higher levels of LDH compared to infection with ser-
otype 2 (D39), 5 and 7F. LDH levels were also significantly higher
at 12 h post infection with ST217S compared to infection with
serotype 5, 6B and 2 (D39).
Serotype 1 pneumolysin damages epithelial tight junctions.
Serotype 1 is able to disseminate from the lungs into blood as
early as 6 h post infection in vivo (Fig. 1b), leading to systemic
infection and high mortality. It also causes early and sustained
LDH release from lung epithelial cells in vitro, suggesting that
translocation from infected lungs into blood in vivo is most likely
due to damage to lung epithelial cell barriers. To further inves-
tigate this, in vitro assays were performed to measure the barrier
function of human primary pulmonary alveolar cells (Fig. 7) and
A549 epithelial cells (Supplementary Fig. 4) during infection with
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Fig. 3 Comparison of Serotype 1 (ST217S) and Serotype 2 (D39) in BALB/c mouse nasopharyngeal carriage model. Mice were infected by intranasal
administration with either 105 CFU of 1(ST217S) or 2(D39) and culled at 0, 1, 3, 7, 14 or 21 days post infection. In all, 5–10 mice per group were culled and
tissues were taken for analysis of bacterial load. Data presented as follows; each symbol represents an individual mouse and error bars show the geometric
mean. Mice infected with 1 (ST217S) are shown by red dots and 2(D39) infected shown as black dots. Statistical analysis was performed using Two-way
ANOVA and Sidaks comparison test. a CFU counts in the nasopharynx of infected mice. ***P value= 0.0008 (b) CFU counts in the Olfactory epithelium of
infected mice. **P value= 0.0025. c CFU counts in the Olfactory Bulb of infected mice. *P value= 0.0341. d CFU counts in the brain of infected mice.
*P value= 0.0200, **P value= 0.0070. Source data are provided as a Source Data file.
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a range of clinical serotypes. A monolayer of cells was infected
with S. pneumoniae, and trans-epithelial electrical resistance
(TEER) measurements taken as an indicator of barrier integrity
(Fig. 7). TEER readings are used as an indicator of the perme-
ability of tight junctions between cells grown in culture39 and
decrease in the TEER value is an indicator of disruption or
damage of tight junctions. Infection of both primary and
immortalised lung epithelial cells with serotype 1 (ST217) resul-
ted in a significant drop in TEER compared to infection with
other isolates of S. pneumoniae (D39, 5 and ST306; Fig. 7a–c).
The addition of liposomes, to bind and sequester pneumolysin
released from ST217, resulted in significantly higher TEER
measurements and therefore less damage to the epithelial barrier
at 24 h post infection (Fig. 7d).
In addition to performing TEER readings on infected
HPAEpiCs, the permeability of the tight junctions was assessed
using FITC-Dextran (Fig. 8), as well as monitoring the expression
of zonula occludens protein 1 (ZO-1) during infection (Fig. 9).
Significantly higher emissions of FITC-dextran were observed on
the basolateral side of HPAEpiCs infected with serotype 1
(ST217) compared to other serotypes, confirming our findings
with TEER readings that suggested that high concentrations of
pneumolysin cause significant damage to epithelial cell tight
junctions. This effect was significantly reduced in the presence of
liposomes. Cell damage by ST217 was independently confirmed
using an MTT assay (Supplementary Fig. 5).
ZO-1 protein localizes at tight junction sites in epithelial and
endothelial cells and fluorescent staining of this protein can be
used to visualise cellular tight junctions40. Infection with D39 or
ST217 induced markedly decreased abundance in total ZO-1
protein as compared to uninfected and ST306-infected cells
(Fig. 9a, b). This effect was most pronounced in ST217-infected
cells. There was also evidence of decreased association of ZO-1
with epithelial membranes in ST217-infected cells (Fig. 9a).
Discussion
Streptococcus pneumoniae serotype 1 is the most prevalent and
invasive pneumococcal serotype in sub-Saharan Africa, although
the bacterial factors driving pathogenesis are not well understood.
Here, we used murine infection models and in vitro assays to
identify key virulence determinants associated with increased
invasiveness of serotype 1.
Previous published work has demonstrated that BALB/c mice
are highly resistant to invasive pneumococcal pneumonia when
200
H
ou
rs
 p
os
t i
nf
e
ct
io
n
a
b
c
175
150
125
100
75
50
25
0
500
100
80
60
40
20
0
Lyt
A-
1 (S
T21
7C) 5
%
 A
u
to
lys
is
400
300
ns
200
100
0
Pn
eu
m
ol
ys
in
 c
on
ce
nt
ra
tio
n 
(ng
 pe
r m
l)
1 (S
T21
7S)
1 (S
T21
7C)
1 (S
T30
18)
1 (S
T30
6) 6B 5 7F
2 (D
39:
ST2
17p
ly)
2 (D
39)
1 (S
T21
7S)
1 (S
T21
7S)
1 (S
T21
7C)
1 (S
T30
81)
1 (S
T30
81)
1 (S
T30
6) 6B146B145 19F19A 23F
PL
N-
A
Co
ntr
ol7F
2 (D
39:
ST2
17p
ly)
2 (D
39:
ST2
17p
ly)
2(D
39)
2 (D
39)
Fig. 4 A combination of pneumolysin production and rates of autolysis
correlate with pneumococcal virulence. a Mice were infected with 1 × 106
colony forming units (CFU) S. pneumoniae by intranasal administration and
monitored closely for signs of ill-health. If infected mice became lethargic,
they were culled, survival times noted and CFU from blood determined by
Miles and Misra dilution. Survival times of mice infected with African
serotype 1 strains (red) compared to other clinically relevant strains (black)
and a D39 strain expressing the ST217S pneumolysin (grey) (10 mice/
group). Experiment was ended at 168 h. Statistical analysis was performed
using One-way ANOVA and Dunnett’s multiple comparisons test:
****P-value < 0.0001 vs D39. b ELISA-based quantification of the amount of
pneumolysin released by different strains and serotypes (107 CFU) upon
lysis by penicillin/streptomycin treatment. Data represented as mean ±
SEM. For all serotypes n= 3 biologically independent samples, whereas for
1(ST217S) and 2(D39), n= 6 are shown (six biologically independent
samples over two independent experiments). Statistical analysis was
performed by one-way ANOVA with Dunnett’s multiple comparison
test. Asterisk represent significant differences versus serotype 2 (D39).
*P < 0.0132, **P < 0.01, ****P < 0.0001, ns= not significant. c Bacteria
(OD600 1.0) were incubated at 37 °C and 175 rpm with 0.01% Triton X. At
60min post treatment, OD600 was measured and converted to a
percentage of the original OD600 reading. Percentage autolysis represents
the percentage decrease of original OD600 reading. Statistical analysis was
performed by Two-way ANOVA and Tukey’s multiple comparisons test.
Rates of autolysis were measured in triplicates; data are presented as mean
± SEM. Asterisk represent comparisons of serotype 1 to 2(D39) and $
represents comparisons of serotype 1 to serotype 5. (ns= non significant.
*P= 0.0103, $$P= 0.0056, ***P= 0.0002, ****/$$$$P < 0.0001). Source
data are provided as a Source Data file.
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intranasally infected with serotype 2 (D39). No bacterial dis-
semination from lungs into bloodstream is observed, and bacteria
are cleared from the lungs within 3–5 days, resulting in 100%
survival rates32,34,41. However, our findings show that when
BALB/c mice were intranasally infected with African serotype 1
(ST217 and ST3018) isolates, 100% mortality was observed as a
result of high levels of bacteremia occurring within 24 h post
infection. Indeed, dissemination of serotype 1 from lungs into
bloodstream occurred as early as 6 hours post infection with
ST217S, demonstrating the highly invasive capacity of serotype 1,
even in normally resistant hosts. This invasive phenotype was
unique to serotype 1, as infection with other clinical serotypes did
not lead to host death. The effect was confirmed to be dependent
upon pneumolysin, as a D39 mutant in which the serotype 2 ply
was replaced with that of serotype 1 ST217 was able to translocate
from lungs to blood (just as ST217 did) and cause 50% mortality
in BALB/c, as well as expressing levels of pneumolysin that were
significantly higher than D39 but comparable to those of ST217.
Sequence comparisons of D39 and ST217 ply showed
6 synonymous single-nucleotide polymorphisms (SNPs) in the
ST217 pneumolysin gene compared to D39 (Supplementary
Fig. 6). Despite these SNPs not leading to amino acid substitu-
tions, mRNA prediction software (RNAfold Web) suggested that
the SNPs observed could alter the secondary structure of
ST217 ply compared to D39 ply (Supplementary Fig. 7). These
structural differences in ST217 ply mRNA may account for the
increased levels of pneumolysin produced by ST217 and by the
D39 mutant expressing ST217 ply.
The initial phase of pneumonia is marked by flooding of the
alveoli with bacteria, but very few inflammatory cells42. Sub-
sequent breaching of endothelial barriers is thought to facilitate
pneumococcal bacteremia and is commonly associated with high
mortality rates43. This often occurs in the absence of a significant
inflammatory response, suggesting that this rapid dissemination
is likely to be driven by bacterial toxin-induced damage of the
lung epithelial barriers. We demonstrate here that different
pneumococcal serotypes produce varying concentrations of
pneumolysin at equivalent CFU. However, the amount of pneu-
molysin produced by serotype 1 was not always significantly
greater than that produced by other serotypes, suggesting that it is
not simply the amount of pneumolysin produced that determines
virulence, but also the rate at which this pneumolysin is released.
Release of pneumolysin is dependent on the activation of
autolysin (LytA) which causes rapid cell wall breakdown and cell
lysis22,27,28. Hence, autolysis is key to enabling release of hae-
molytic pneumolysin to quickly compromise host defences before
a robust immune response can be generated. Indeed, autolysin
(LytA-) deficient pneumococcal strains have been shown to be
less virulent after intranasal administration into mice12,27,28.
However, an often overlooked factor is the role played by the rate
of autolysis in determining disease progression. A case in point is
serotype 5, which produces a high quantity of toxin, but which
does not cause mortality or disseminate into the bloodstream
during pneumonia in BALB/c mice. Notably, autolysis is sig-
nificantly slower in serotype 5 than in African serotype 1 isolates,
suggesting that pneumolysin release by serotype 5 may not be
rapid enough to avoid detection or overcome host defenses
in vivo. Although the D39 strain expressing ST217 pneumolysin
(D39:ST217ply) showed initially high rates of autolysis compared
to the D39 parental strain, this effect did not last beyond 120
minutes post Triton-X treatment. Hence, despite D39:ST217ply
exhibiting elevated autolysis rates relative to D39 (albeit
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Fig. 5 High concentration of pneumolysin in infection dose correlates with high mortality rates in BALB/c mice. a In separate tubes, 2 × 107 CFU per ml
of 1 (ST217S), 2(D39), serotype 5 and PLN-A were prepared in PBS. Dose preparations were incubated at room temperature for 60min before a sample of
supernatant was removed and pneumolysin detection ELISA used to quantify the amount of pneumolysin released into the supernatant for each strain.
Experiments were performed in triplicate and error bars represent mean ± SEM. Statistical analysis was performed using a one-way ANOVA and Tukey's
multiple comparison test. b Survival times of mice infected with different combinations of 106 CFU of either serotype 1 (ST217S) or serotype 2 (D39)
S. pneumoniae in 50 μl bacterial dose supernatant that had been incubated at room temperature for 60min, 10 mice per group. For one group of mice, the
supernatant from ST217S was treated with liposomes (a combination of 2 μg/ml Cholesterol:sphingomyelin (66mol/%cholesterol) and sphingomyelin-
only liposomes) for 30min. Each symbol represents one mouse. Errors bars represent mean ± SEM. Statistical analysis was performed using One-way
ANOVA and Tukey’s multiple comparison test: *P-value= 0.0398, **P-value < 0.0093 and ****P-value < 0.0001. Source data are provided as a Source
Data file.
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transient), overall, it had reduced autolysis rates relative to
other serotype 1 isolates, which may explain why the D39:
ST217ply strain showed an intermediate virulence phenotype
in vivo.
This is supported by observations made in vitro, when
different bacterial cultures were incubated with both A549 lung
epithelial cells and primary human pulmonary alveolar epithelial
cells. When comparing A549 cell infection with serotype 1
(ST217) to other clinical serotypes, significantly higher levels of
epithelial cell cytotoxicity (quantified by supernatant LDH levels)
was observed as early as 6 h post infection, suggesting that
rapid release of pneumolysin by African serotype 1 causes high
cellular cytotoxicity to lung epithelial cells in the context of
pneumonia infection. In addition, compared to other serotypes
tested, ST217 caused significant damage to human primary
lung alveolar epithelial cell barriers, as measured using trans-
epithelial electrical resistance readings (TEER) and FITC-Dextran
permeability assays. This damage was significantly reduced by
24 h post infection with the addition of liposomes, which bind to
and sequester pneumolysin. Significantly greater damage to epi-
thelial cell barriers and increases in cellular cytotoxicity by
pneumolysin released by serotype 1 isolates are likely to be the
main causes of bacterial dissemination observed from lungs into
blood and from nasopharynx to brain, in murine models of
infection.
Additionally, ZO-1 protein was significantly reduced when
lung epithelial cells were infected with ST217 or D39, but not
ST306, confirming the impact of haemolytic-pneumolysin
expressing serotypes on epithelial tight junctions. ZO-1 is part
of a zonula occludens complex (ZO-1, ZO-2, ZO-3), and it is the
first to be expressed during the formation of intercellular tight
junctions44. The loss of ZO-1 was most pronounced in ST217-
infected cells, in line with our previous findings that this sequence
type rapidly releases pneumolysin. The breakdown of this anchor
protein leads to the dissociation of the cell actin cytoskeleton,
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Fig. 7 African Serotype 1 causes significant damage to epithelial cell barriers. Human primary alveolar epithelial cells (HPAEpiCs) were cultured on
trans-well inserts for 3 days to establish a monolayer. In all, 105 cfu of S. pneumoniae were added and trans-epithelial electrical resistance readings (TEER)
were taken at 6, 12 and 24 h post infection to assess the damage to tight junctions between epithelial cells. White bars represent control uninfected wells.
a Comparison between serotype 1 (ST217S) (red bars) and serotype 2 (D39) (black bars) infection. ****P-value < 0.0001. b Comparison between 5
(diagonal hashed bars) and serotype 1 (ST217S). ***P-value= 0.0003, ****P-value < 0.0001. c Comparison between serotype 1 (ST306) (horizontal striped
bars) and serotype 1 (ST217S). ***P-value= 0.0001, ****P-value < 0.0001. d Comparison between serotype 1 (ST217S) (red bars) and serotype 1 (ST217S)
with the addition of liposomes (red diagonally hashed bars). Clear, diagonally hashed bars represent cells treated with liposomes only. ****P-value <
0.0001. TEER readings were performed in triplicate from duplicate wells from three independent experiments. All statistical analysis was performed using
Two-way ANOVA and Tukey’s multiple comparison test. Error bars represents the SEM. Source data are provided as a Source Data file.
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Fig. 6 Level of lung epithelial cell cytotoxicity during infection varies with
serotype. A549 lung epithelial cells were infected with 6 × 105 CFU S.
pneumoniae and, at 6 and 12 h post infection, samples of cell culture
supernatant were removed and amount of LDH (an indicator of cytotoxic
damage) measured. Infections were performed in triplicate wells and error
bars represent the mean ± SEM from three independent experiments. Bars,
from left to right, are non-infected control cells (green), serotype 1 (ST306)
infected (horizontal bars), 2(D39) infected (black), 6B infected (dotted
bars), 5 infected (diagonal bars), 7F infected (grey squared bars) and 1
(ST217S) infected (red bars). White bars show the LDH positive control.
Statistical analysis was performed using Two-way ANOVA and Dunnett’s
multiple comparison test. Source data are provided as a Source Data file.
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which may provide a route for paracellular invasion of epithelial
cells by ST217, hence aiding its invasiveness.
Based on our findings, we propose that the relationship
between the amount of toxin produced and its rate of autolysis-
dependent release is a key determinant of invasiveness. The
combination of these factors drive and control serotype 1 viru-
lence. The proposed mechanism of virulence is explained in
summary Fig. 10. Upon entry into the lungs, serotype 1 is likely to
undergo rapid autolysis. Increased rates of autolysis will result in
rapid release of high concentrations of pneumolysin, which are
toxic to lung epithelial cells and cause breakdowns in tight
junctions between cells. Increased cellular cytotoxicity and cell
permeability allows for bacterial dissemination from lungs into
the blood stream where disease progresses to bacteraemia and
results in high mortality levels.
The factors governing in vivo autolysis rates largely remain
elusive, but may include contributions from the extra-host
environment. Indeed, the contribution of environmental factors
to African serotype 1 autolysis was highlighted in a recent study,
which found that increases in temperature dramatically increased
rates of pneumococcal autolysis, leading to increased release of
pneumolysin and higher attack rates (invasiveness) of pneumo-
cocci colonising the nasopharynx45. Given the inherently high
rates of autolysis described here for African serotype 1, its sen-
sitivity to higher temperatures may make a significant contribu-
tion to invasive serotype 1 disease in sub-Saharan Africa.
Epidemiological studies of countries in the African meningitis
belt have shown that S. pneumoniae serotype 1 causes up to 79%
of meningitis cases among older children and working age
adults46. Data from our murine nasopharyngeal carriage studies
demonstrate that serotype 1 disseminates into olfactory tissue and
subsequently brain tissue during asymptomatic carriage; an event
not observed during serotype 2 colonisation. During infection,
rapid autolysis and release of pneumolysin by serotype 1 may
enable bacterial dissemination from the nasopharyngeal tissues to
the brain via the olfactory bulb. This phenomenon may con-
tribute to the high burden of serotype 1 pneumococcal meningitis
in the African meningitis belt.
The potency of free/released pneumolysin in supernatants
taken from serotype 1 ST217 inoculum doses was clearly
demonstrated when these supernatants were used to drive
increased invasiveness of serotype 2 (D39) in a mouse pneumonia
model. Addition of ST217 supernatant was sufficient to increase
mortality in D39 infection from 0 to 60%. These results
demonstrate that serotype 1 pneumolysin is key in driving bac-
terial dissemination from the lungs into blood, resulting in high
mortality rates. Furthermore, D39, which produces lower quan-
tities of pneumolysin, is capable of significantly increased viru-
lence and proliferation in blood if aided across the lung epithelial
barrier by serotype 1 pneumolysin, suggesting that penetration of
the lung epithelial barrier is the key step in the progression to
bacteremia and lethality. Enhanced virulence of D39 when
combined with ST217 supernatant was completely reversible with
the addition of liposomes that bound and neutralised pneumo-
lysin38. The results from these supernatant swap experiments
suggest that therapies that target pneumolysin may have sig-
nificant therapeutic potential in cases of severe pneumococcal
pneumonia, where risk of bacterial dissemination into the blood
is high. Induction of neutralising anti-toxin antibodies via vac-
cination with a pneumolysin- or toxoid-containing vaccine may
also prevent the key tissue-invasive steps that lead to severe
manifestations of disease47,48.
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Fig. 8 African Serotype 1 causes significant increases to human primary alveolar epithelial cell barrier permeability. Assessment of epithelial cell barrier
permeability changes during infection with different S. pneumoniae serotypes was performed using fluorescein isothiocyanate (FITC)-dextran (70 kDa, 1 mg
per ml), see methods for full details. White bars represent FITC-Dextran emissions from untreated cells. Error bars represent mean ± SEM. Statistical
analysis was performed using Two-way ANOVA and Tukey’s multiple comparison test. a Comparison of FITC-Dextran excitation emission between
serotype 2(D39) (black bars) and 1 (ST217S) (red bars). ****P-value < 0.0001. b Comparison of FITC-Dextran excitation emission between serotype 5
(diagonally hashed bars) and 1 (ST217S) (red bars). *P-value= 0.0178, ***P-value= 0.0007, ****P-value < 0.0001. c Comparison of FITC-Dextran
excitation emission between serotype 1 (ST306) (horizontal bars) and 1 (ST217S) (red bars). ****P-value < 0.0001. d Comparison of FITC-Dextran
excitation emission between serotype 1 (ST217S) infection with (red, diagonally hashed bars) and without (red bars) the addition of liposomes. ****P-value
< 0.0001. As a control, cells were also treated with liposomes in the absence of bacteria (black bars, second column). Source data are provided as a Source
Data file.
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The results presented here offer insight into why serotype 1
isolates have a high propensity to cause invasive disease. Our
findings demonstrate the key relationship between the amount of
toxin produced and its release rate as a determinant of serotype 1
invasiveness and pathogenicity.
Our findings also have implications for our overall under-
standing of pneumococcal disease pathogenesis, whereby high
attack rates may in part result from production of large quantities
of pneumolysin, quickly released by rapid autolysis. This high-
lights the significance of pneumolysin for consideration in future
vaccine design and as a key target for new adjunctive therapies.
Methods
Ethics statement. This study was performed in strict accordance with UK Home
Office guidelines. Animal experiments were performed at the University of
Liverpool and were approved by the local animal welfare and ethics committee.
Mice. For all experiments, 6–10-week-old female BALB/c mice were purchased
from Harlan Laboratories (Bicester, UK), and allowed to acclimatise for 7 days
prior to use. The animals were housed in the animal facilities under the following
conditions; temperature was 21–23 °C and humidity set at 55–65%. Mice were
placed in individually ventilated cages (IVC) from Technoplast (GM500). Auto-
matic watering provided reverse osmosis water sterilised by UV radiation and
enrichment included nesting material, balcony, dome home and handling tunnel.
Bacteria. Pneumococci were cultured on blood agar base containing 5% vol/vol
horse blood overnight at 37 °C 5% CO2.. Single colonies of pneumococci were
isolated and cultured in brain heart infusion broth (Oxoid, UK) containing 20%
(vol/vol) fetal bovine serum until required optical density was reached27. See
Supplementary Table 2 for details of all S. pneumoniae serotypes used in this study.
Construction of pneumococcal D39:ST217ply mutant. Generation of competent
S. pneumoniae D39 cells and subsequent transformation were performed using
complete transformation medium (C+ Y media, pH= 6.8) method49. D39
expressing serotype 1 pneumolysin was constructed by replacing the wild-type
D39-ply open reading frame with a cassette composed of the serotype 1-ply gene
followed by the aphA3 gene (conferring kanamycin resistance) and subsequent
selection of kanamycin-resistant transformants (D39:ST217ply-aphA3) on blood
agar base medium supplemented with kanamycin. Transformants were verified by
Sanger sequencing. The primers used for mutant construction were: Ply-up-for
gatgagcgcgacccagtgccag, Ply-up-rev cagatatccgcagagagatcatcgc, Ply-down-for
tggatcctgcttgagtttatctcttgcctagcg, Ply-down-rev gggcttgtttagcacggtcgataac, aphA3-
for ctctgcggatatctgtcgctagtattaaatgc, aphA3-rev tcaagcaggatccatcgatac.
Preparation of challenge dose. Aliquots of S. pneumoniae were stored at −70 °C.
When required, suspension was thawed at room temperature and bacteria were
harvested by centrifugation before being resuspended in sterile phosphate-buffered
saline (PBS).
Infection of mice. Animals were anesthetised with a mixture of O2 and Isofluorane
and infected intranasally with 1 × 106 CFU S. pneumoniae in 50 μl of PBS as
described previously27. For nasopharyngeal carriage models, inoculation dose was
reduced to 1 × 105 CFU in 10 μl of PBS50. Mice were periodically scored for clinical
signs of disease and culled when they became moderately lethargic or else at pre-
determined times post infection. Signs of disease were based on the scheme of
Morton51. Mice were culled by cervical dislocation and lungs were removed and
prepared for assessment of bacterial colony-forming units. Blood samples were
taken from tail bleeds or cardiac puncture under terminal anaesthesia.
Determination of bacterial numbers in nasopharynx, lung and blood. Viable
counts of bacteria in lung, nasopharynx, olfactory tissues, brain and blood samples
were determined by serial dilution in sterile 1x PBS and plating on blood agar
containing 5% (v/v) defibinated horse blood and 40 μg per ml of Gentamycin
(Sigma). Plates were incubated overnight at 37 °C 5% (v/v) C02 and bacterial
colony numbers were assessed the following day.
Tissue preparation (murine lungs). Lung tissue was harvested, weighed, placed
into a petri dish and then cut into smaller pieces using a scalpel blade. To help
release immune cells via enzymatic digestion, lung tissue was placed in 1.5 ml
Eppendorf tubes containing 1 ml of PBS and 10 mg per ml of Collagenase D
(Roche). The Eppendorf tubes were then incubated at 37 °C for 30 min. After
digestion, tissue was passed through a 40-μm cell strainer (BD Biosciences) and
washed with sterile PBS to create a single-cell suspension. Cell suspensions were
then centrifuged at 400 × g for 5 min. The cell pellet was resuspended in 1x Red
blood cell lysis buffer (Sigma) to lyse all red blood cells. The cell suspensions were
then centrifuged at 400 × g for 5 min and cell pellet resuspended in cryopre-
servation media, for storage at −80 °C. When needed, aliquots of cells were thawed
quickly in the water bath.
Tissue preparation (murine nasopharynx). Nasopharyngeal tissue was harvested
and placed into bijou tubes containing 3 ml of sterile PBS. The tissue was then
mechanically disrupted for ~1 min using a homogenizer (IKA T10). The homo-
genised tissue was then passed through a 40-μm pore cell strainer and centrifuged
at 400 × g for 5 min. The cell pellet was either resuspended in cryopreservation
media or used for flow cytometry analysis on the same day.
Flow cytometry. Nasopharynx and lung tissue were collected and prepared as
described above. For staining and acquisition, samples were either thawed or used
fresh from dissection. Cells were incubated with a 1 in 200 dilution of purified anti-
CD16/CD32 Fc blocking antibody (eBiosciences) for 30 min at room temperature.
Following incubation with blocking antibody, cell surface markers were stained for.
An intracellular monoclonal antibody panel was used to detect both intracellular
cytokines and transcription factors for different CD4+ T cell subsets. The samples
were acquired using a BD FACSCanto flow cytometer (BD Biosciences). See
supplementary Table 3 for details of antibody panels used. Supplementary
Figs. 9–11 show the gating strategies used to idenitify immune cells of interest.
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Fig. 9 Pneumococcal infection causes degradation of cellular tight
junctions. a Fluorescent image of Human pulmonary alveolar epithelial cells
(HPAEpiC) stained with an antibody against zonula occludens (ZO-1). Cells
were co-incubated for 12 h with phosphate buffer saline (PBS), serotype 2
(D39), serotype 1 (sequence type 306) and serotype 1 (sequence type 217)
at an MOI of bacteria cells – 10:1. Scale= 50 μm. b Corrected Total Cell
Fluorescence (CTCF) of HPAEpiCs tagged with an antibody against ZO-1.
CTCF was calculated by selecting six cells from each merged image.
Integrated density, the total area of the cell, and the mean fluorescence of
background readings were used to acquire total fluorescence. Results from
triplicate experiments shown and error bars represent mean ± SEM.
Statisitcal analysis performed using one-way ANOVA and Tukey’s multiple
comparison test: *P-value= 0.0460 and **P value= 0.0045. Source data
are provided as a Source Data file.
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Autolysis assay. Triton X-100 induced autolysis assays were performed in tri-
plicate as previously described, with the following modifications52. Cultures of S.
pneumoniae were subcultured into 20 ml of fresh BHI broth and incubated at 37 °C
and 200 rpm until an approximate A600 of one was obtained. Cultures were cen-
trifuged for 10 min at maximum speed. Pellets were resuspended in 1 ml of fresh
PBS and the A600 was adjusted to 1 in 1 ml of PBS containing 0.01% Triton X-100
(Sigma) in a cuvette. Cuvettes were covered in parafilm and samples vortexed for
10 s and the A600 of the culture at time zero was recorded. Cultures were then
incubated at 37 °C and 200 rpm for 3 h and the A600 was measured every 15 min.
Triton X-100 induced autolysis was presented as a percentage of the initial A600 at
time zero.
In vitro lung epithelial cell infection. Human lung adenocarcinoma epithelial cell
line, A549 (Sigma) and human primary pulmonary alveolar epithelial cells
(acquired from ScienCell Research Laboratories – Cat. No 3200) were used to
assess cellular damage, disruption to epithelial cell tight junctions and cytokine
responses to infection with S. pneumoniae. All cells were tested for mycoplasma
contamination prior to starting experiments. A549 cells were maintained in
DMEM supplemented with 10% foetal bovine serum whilst Alveolar Epithelial Cell
Medium (AECM) was used for human primary pulmonary alveolar epithelial cells.
In all, 500 μl of cells at 2 × 105 cells per ml density were seeded onto Greiner
Thincerts (surface area 0.94 cm2, 3 μm pore diameter). Inserts were placed in 12-
well tissue culture plates (Greiner) and incubated in 1.5 ml of appropriate cell
culture media at 37 °C, 5% CO2 for 2 days. Frozen bacterial stocks were thawed,
and suspended to a desired final concentration in DMEM+ 10% FBS or AECM
before addition to tissue culture inserts.
Trans Epithelial Electrical Resistance measurement. Trans Epithelial Electrical
Resistance measurement (TEER) was measured in Ohms using an EVOM2 Epi-
thelial Voltohmmeter (WPI). Wells without cells were used as blank standard.
Measurements were done in triplicate and the mean was calculated and blank
subtracted. Blank corrected resistance values were multiplied by 0.94 (the surface
area of insert) give TEER in Ohms × cm2.
Immunocytochemistry. Briefly, coverslips containing human primary pulmonary
alveolar epithelial cells (HPAEpiCs) were washed twice with phosphate-buffered
saline (PBS, pH 7.6) and fixed with fresh high-grade 4% paraformaldehyde (PFA)
for 10 min. The PFA was aspirated and the coverslips were washed 4 times in PBS
for 5 min each time. The coverslips were blocked with 1.5% Normal Goat Serum
(NGS, Sigma Aldrich UK) for 2 h at room temperature. Primary antibody incu-
bation was carried out for 2 h at room temperature or overnight at 4 °C with gentle
agitation. HPAEpiCs were identified by using a Zonula Occludens primary anti-
body (Rb polyclonal anti ZO-1 – Abcam ab96587). ZO-1 antibody was used in a
1:100 dilution and the samples were washed in PBS for 5 × 5 min. The corre-
sponding secondary antibody (goat anti-rabbit IgG Abcam ab96883) conjugated to
Dylight® (1:1000) was added to the cells for 2 h at room temperature with gentle
agitation. Cells were washed in PBS for 5 × 5 min, and the coverslips were inverted
onto a drop of mounting medium containing DAPI (FluoroshieldTM Sigma
Aldrich UK) on a microscope slide, and stored at 4 °C. The immunostained cells
were viewed under fluorescence (Nikon Eclipse 80i fluorescent microscope) with
the appropriate excitations for each fluorophore. All images were analysed using
ImageJ-Win64.
Measuring cell fluorescence. To determine the level of cellular fluorescence using
microscopy, ImageJ-Win64 software was used as described previously53. In brief,
an outline was drawn around each cell to measure the area and mean fluorescence,
along with several adjacent background readings. The corrected total cell fluores-
cence was calculated as follows:
CTCFð Þ ¼ integrated density
 area of selected cells ´ mean fluorescence of background readingsð Þ
Alveolar permeability assays. Transwell ThinCertsTM (pore size 3.0 μm, 8.4mm
diameter, polyester membrane, Greiner Bio-One, Stonehouse, UK) were coated with
Poly-D-Lysine Hydrobromide (Sigma Aldrich, UK). The lower compartments of the
Transwell chambers were filled with 1.5ml Alveolar Epithilial Cell Medium
(AECM). HPAEpiCs in 500 μl AECM (5 × 104 cells per well) were seeded on the
Thincert’s membrane and reached confluency 24 h post seeding. Cells were coin-
cubated with the appropriate pneumococcal serotype for 6, 12 and 24 h before
fluorescein isothiocyanate (FITC)-dextran (70 kDa, 1 mg/ml; Sigma-Aldrich, Irvine,
UK) was added to the apical side. In all, 100 μl samples were collected at 0 and
60min after the FITC addition from the top and the lower compartment. Our
Thincert setup was gently agitated for the duration of the permeability assay.
Fluorescence (ex: 485 nm; em: 535 nm) was measured using a BMG Omega fluor-
escent plate reader. The mean fluorescence recorded from the lower compartment of
naive cells at the collection point of FITC (60 min) was given the value of 1. Changes
to the experimental Thincerts is compared against the control FITC levels. The
absolute permeability P [cm per s] was calculated by the following equation54:
P ¼ ½Ct  Ct0 ´V=A ´ t ´ C0 ð1Þ
C(t) is the FITC solution found on the lower compartment (μg per ml), 60 min
after the solution was added to the Thincerts, C(t0) is the concentration of FITC
solution at 0 min, t is the duration of the flux (seconds), V is the volume of the
solution found in the lower compartment (cm3), A is the surface of the Thincert
membrane (33 mm2) and C0 is the original concentration of the FITC solution
added on the apical side (μg per ml). FITC concentrations were calculated in
accordance to a FITC-dextran standard curve.
Cell viability assays. Prior to the assay, 96-well flat-bottomed micro-plates were
coated with 15% Poly-D Lysine Hydrobromide solution, and seeded with 5 × 104
cells per well (total cell media volume of 200 μl per well). The micro-plates were
incubated at 37 °C/5% CO2 for 24 h. The supernatant was carefully removed and
the cells were washed with 100 μl 1xPBS.
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. The
MTT assay measures the reduction of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) to formazan within living cells. MTT solution was
Serotype 1 infected lungs
Autolytic bacteria
Tight junction
Pneumolysin
Epithelial cell barrier Epithelial cell barrier
Tight junction
Autolytic bacteria
Pneumolysin
Blood vessel Blood vessel
S. pneumoniae (ST217) S. pneumoniae
S. pneumoniae infected lungs
Fig. 10 Comparison of pneumococcal pneumonia in serotype 1 compared to serotype 2 infection. In a serotype 1 (ST217/ST3081) infected lung, levels of
bacterial lysis are high, resulting in release of high concentrations of the toxin pneumolysin. These high levels of pneumolysin cause damage to tight
junctions between epithelial cells and levels of cell cytotoxicity are high. Subsequent damage to lung epithelial cell barriers allows for serotype 1
pneumococci to disseminate from the lungs into the bloodstream and cause bacteraemia. In pneumonia caused by other S. pneumoniae serotypes such as 2
(D39), rates of bacterial lysis are lower and therefore lower concentrations of pneumolysin are released into the lung. This results in lower cell cytotoxicity
and reduced damage to cell barriers between lungs and blood, allowing for containment of bacteria within the lungs and therefore no development of
bacteraemia.
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prepared by the addition of 1 mg MTT (Sigma Aldrich®) to 1 ml of phenol red-free
media (Gibco®).
Cell culture media was removed and wells were washed with 100 μl PBS
followed by the addition of 100 μl MTT (1 mg per ml) per well protected from
light. The plate supplemented with MTT was incubated at 37 °C/5% CO2 for 4 h.
Following incubation, light microscopy was used to observe whether formazan
crystals had formed within the cells. Then the supernatant was removed by
aspiration and 100 μl of isopropanol was added to the wells to dissolve the crystals
formed. Colour change was assessed by absorbance at 560 nm using a
ThermoScientific Multiskan plate-reader with the SkanIt (Research Edition) for
Multiskan Spectrum 2.2 software.
Liposomes. Cholesterol and sphingomyelin liposomes were obtained from egg yolk
(Sigma Aldrich). Lipids were individually dissolved in chloroform at 1 mg per ml
concentrations. For preparation of liposomes, individual lipids were mixed to form
Cholesterol:sphingomyelin (66mol/%cholesterol) and sphingomyelin-only lipo-
somes. Chloroform was completely evaporated with nitrogen gas for 30min, fol-
lowed by hydration with PBS (ThermoFisher Scientific). Following incubation for
30min at 45 °C in an Eppendorf thermomixer with vortexing, liposome preparations
were sonicated for 30min at 4 °C. Final concentration of liposomes was 2mg/ml.
Pneumolysin ELISA. ELISAs were used to detect the amount of pneumolysin
produced by different serotypes of S. pneumoniae (107 CFU per ml) when bacteria
were lysed with penicillin/streptomycin antibiotics over the course of an hour at
room temperature. Bacterial CFU counts were performed to check full lysis with
antibiotics had occurred. In addition, all isolates were checked for penicillin
resistance (Supplementary Fig. 8) The ELISA was also used to detect the amount of
pneumolysin released into the supernatant when 107 CFU per ml of S. pneumoniae
when cultured in PBS for 45 min. ELISA plates were coated with 1 μg per well of
IgG1-Ply4 (Abcam 71810) and incubated overnight at 4 °C before washing and
blocking with Peprotech Blocking Buffer (1% BSA in PBS). Purified recombinant
Ply (allele 1, D39) of various concentrations was included as the standard curve in
the assay (2-fold dilutions from 400 ng/ml to 3.125 ng/ml), which was incubated
for 1 h at 37 °C. After samples were added and incubated, 1 µg per ml of detection
antibody (Rabbit polyclonal to PLY antibody, Abcam ab71811) was added to the
wells and incubated for 2 h at room temperature. Goat anti-rabbit IgG alkaline
phosphatase (Abcam Ab97048) (1:5000 dilution) was added to wells for 30 min at
room temperature. After washing, the colour reagent Alkaline Phosphatase yellow
pNNP (Sigma p7998) was added and plate incubated for 30 min in the dark. The
amount of pneumolysin present was assessed by measuring the plate at 405 nm
with an ELISA plate reader. Recorded values for the recombinant pneumolysin
were used to plot a curve of OD405 vs ng/ml pneumolysin concentration and test
samples were quantified in ng per ml using the equation of the curve.
Haemolytic assay. In all, 4% red blood cell solution was prepared by adding 400 µl
of sheep blood pellet to 10 ml of PBS. Bacterial stocks were thawed, centrifuged and
resuspended to 1 × 107CFU per ml. Bacteria were lysed using Penicillin and
Streptomycin antibiotics at room temperature for 30 min and Miles and Misra
counts were performed to check for 100% lysis (Supplementary Fig. 8). A 1:1 ratio
of lysed bacteria to 4% RBC solution was added to a microplate before bacteria was
diluted twofold with 4% RBC solution. After 30 min incubation the plate was
centrifuged and supernatant was removed from each well and placed in a micro-
plate. The OD was measured at 540 nm on a spectrometer to determine the levels
of haemoglobin released.
Statistics. Statistical analysis was carried out using the GraphPad Prism 6® version
5 statistical package (GraphPad Software, Inc). The statistical significance
according to the P-values were summarised as follows: *P-value < 0.05, **P-value
< 0.01, ***P-value < 0.001 and ****P-value < 0.0001. Reported measurements are
from distinct samples and not repeated measures.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The source data underlying Figs. 1, 3–9, and Supplementary Figs. 1–5, are provided as a
Source Data file.
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